United Therapeutics Corporation Stock Forecast
Stronger technical forecast for United Therapeutics Corporation stock price after Friday trading.
(Updated on Apr 26, 2024)
The United Therapeutics Corporation stock price fell by -0.89% on the last day (Friday, 26th Apr 2024) from $235.95 to $233.85. During the last trading day the stock fluctuated 1.66% from a day low at $233.64 to a day high of $237.53. The price has risen in 6 of the last 10 days and is up by 0.54% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 356 thousand shares were bought and sold for approximately $83.23 million.
Given the current short-term trend, the stock is expected to rise 11.30% during the next 3 months and, with a 90% probability hold a price between $260.27 and $293.56 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
UTHR Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The United Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $235.74 and $236.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -6.28%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for United Therapeutics Corporation stock
United Therapeutics Corporation finds support from accumulated volume at $229.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $3.89 between high and low, or 1.66%. For the last week the stock has had daily average volatility of 2.20%.
Our recommended stop-loss: $220.40 (-5.75%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 33 days ago.)
Trading Expectations (UTHR) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect United Therapeutics Corporation to open at $235.01, and during the day (based on 14 day Average True Range), to move between $228.06 and $239.64, which gives a possible trading interval of +/-$5.79 (+/-2.48%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 4.95% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $235.78 (0.83%) than the support at $229.72 (1.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
United Therapeutics Corporation will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is $5.63. We will update the financials statements for United Therapeutics Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.84% in the first trading day after earnings release.
Is United Therapeutics Corporation stock A Buy?
United Therapeutics Corporation holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.036 Hold/Accumulate Upgraded
Predicted Opening Price for United Therapeutics Corporation of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $235.01 ( 0.495%) | $233.85 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for UTHR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 238.90 | 2.16 % | |
| R2 | 237.41 | 1.52 % | ||
| R1 | 236.49 | 1.13 % | ||
| Current price: | 233.85 | |||
| Support | S1 | 233.52 | -0.141 % | |
| S2 | 232.60 | -0.533 % | ||
| S3 | 231.12 | -1.17 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 244.26 | 4.45 % | |
| R2 | 236.93 | 1.32 % | ||
| R1 | 235.78 | 0.83 % | ||
| Current price | 233.85 | |||
| Support | S1 | 229.72 | -1.77% | |
| S2 | 228.26 | -2.39% | ||
| S3 | 225.64 | -3.51% |
FAQ
Click here for our free guide on how to buy United Therapeutics Corporation Stock.
